Strong reduction CV events in FH patients with ApoB-inhibitor3' education - May 24, 2015 - ISA Amsterdam, May 24, 2015 - Dr. Paul Barton Duell
ISA2015 | Clinical Breakthroughs Dr. Paul Barton Duell (endocrinologist, Portland, USA) presented a striking reduction of MACE with treatment with the antisense oligonucleotide against apoB mRNA mipomersen in a very high risk population.
News • 4-8-2014
News • 25-5-2015
CETP-inhibitor reduces non-HDL-cholesterol via reducing PCSK9 and enhancing hepatic remnant clearanceISA 2015 Using a humanised mouse model, investigators reveal mechanism via which CETP-inhibitor anacetrapib reduces non-HDL-c.
News • 24-5-2015
News • 23-3-2015
News • 18-3-2015